Subcutaneous Merkel Cell Carcinoma in a Psoriatic Patient Treated with Methotrexate and TNF-α inhibitors

Abstract TNF-α inhibitors are used for the treatment of chronic inflammatory diseases and provide a high degree of clinical efficacy in patients with severe psoriasis. Although the effect of blocking agents gives significant improvements in quality of life of psoriatic patients, the use of them might lead to neoplasia not observed before the treatment. We present a case of Merkel cell carcinoma in a patient with a long-standing history of psoriasis and psoriatic arthritis treated with methotrexate and TNF-α inhibitors (etanercept and infliximab).

[1]  V. Koljonen,et al.  Lateral distribution of Merkel cell carcinoma in a nationwide cohort , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  M. Lapeyre-Mestre,et al.  Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses , 2012, PloS one.

[3]  P. Moore,et al.  Merkel cell carcinoma: a virus-induced human cancer. , 2012, Annual review of pathology.

[4]  S. Haferkamp,et al.  Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. , 2011, The Journal of investigative dermatology.

[5]  J. Taube,et al.  Merkel cell carcinoma: update and review. , 2011, Seminars in cutaneous medicine and surgery.

[6]  S. Krishna,et al.  Merkel cell carcinoma in a patient treated with adalimumab: case report. , 2011, Cutis.

[7]  O. Ruuskanen,et al.  Serological evidence of Merkel cell polyomavirus primary infections in childhood. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[8]  J. Pfeifer,et al.  Merkel Cell Polyomavirus: A Specific Marker for Merkel Cell Carcinoma in Histologically Similar Tumors , 2009, The American journal of surgical pathology.

[9]  D. Galloway,et al.  Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma , 2009, Journal of the National Cancer Institute.

[10]  H. Joensuu,et al.  Incidence of Merkel cell carcinoma in renal transplant recipients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  L. Naldi,et al.  European S3‐Guidelines on the systemic treatment of psoriasis vulgaris , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  Jérôme Couturier,et al.  Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis , 2009, The Journal of pathology.

[13]  P. Simmonds,et al.  Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals. , 2009, The Journal of infectious diseases.

[14]  B. Thiers,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2009 .

[15]  M. Werner,et al.  Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. , 2008, Cancer research.

[16]  P. Calzavara Pinton,et al.  Merkel cell carcinoma and HIV infection: a case report and review of the literature. , 2007, AIDS patient care and STDs.

[17]  F. Saporito,et al.  Rapid growth of Merkel cell carcinoma after treatment with rituximab. , 2006, Journal of drugs in dermatology : JDD.

[18]  L. Clegg,et al.  Epidemiology of primary Merkel cell carcinoma in the United States. , 2003, Journal of the American Academy of Dermatology.

[19]  R. Stern,et al.  Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. , 1998, The New England journal of medicine.

[20]  C. Bunker,et al.  Merkel cell carcinoma arising after therapeutic immunosuppression , 1997, The British journal of dermatology.